Mark S. Link
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Cardiomyopathy and Myosin Studies
- Cardiovascular Effects of Exercise
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
- Emergency Medicine top 0.02%
- Cardiac Arrest and Resuscitation
Papers in
-
- Cardiovascular Effects of Exercise 108
- Cardiac electrophysiology and arrhythmias 75
- Cardiac pacing and defibrillation studies 73
- Cardiac Arrhythmias and Treatments 71
- Cardiomyopathy and Myosin Studies 61
- Cardiovascular Function and Risk Factors 23
- Atrial Fibrillation Management and Outcomes 22
-
- Cardiac Arrest and Resuscitation 69
- Co-authors
- Barry J. Maron (78 shared papers)N.A. Mark Estes (116 shared papers)Martin S. Maron (40 shared papers)James E. Udelson (17 shared papers)Steve R. Ommen (8 shared papers)Paul J. Wang (61 shared papers)Clyde W. Yancy (10 shared papers)Rick A. Nishimura (6 shared papers)
- Journals
- Circulation (51 papers)Journal of the American College of Cardiology (40 papers)Heart Rhythm (30 papers)The American Journal of Cardiology (23 papers)Journal of Cardiovascular Electrophysiology (22 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Mark S. Link
305 papers receiving 23.0k citations
Mark S. Link's Hit Papers
Peers
Comparison fields: 5 of 165
- Cardiology and Cardiovascular Medicine 16.3k
- Emergency Medicine 3.9k
- Orthopedics and Sports Medicine 1.2k
- Surgery 3.3k
- Complementary and alternative medicine 478
Countries citing papers authored by Mark S. Link
This map shows the geographic impact of Mark S. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Link more than expected).
Fields of papers citing papers by Mark S. Link
This network shows the impact of papers produced by Mark S. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Link. The network helps show where Mark S. Link may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 329 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy Hit paper breakdown → | 2011 | 1651 |
| 2 | Part 8: Adult Advanced Cardiovascular Life Support Hit paper breakdown → | 2010 | 1197 |
| 3 | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy Hit paper breakdown → | 2011 | 915 |
| 4 | Part 7: Adult Advanced Cardiovascular Life Support Hit paper breakdown → | 2015 | 849 |
| 5 | Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction Hit paper breakdown → | 2006 | 750 |
| 6 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary Hit paper breakdown → | 2020 | 742 |
| 7 | Exercise and Acute Cardiovascular Events Hit paper breakdown → | 2007 | 732 |
| 8 | Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy Hit paper breakdown → | 2000 | 728 |
| 9 | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary Hit paper breakdown → | 2011 | 616 |
| 10 | 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Hit paper breakdown → | 2012 | 512 |
| 11 | Arrhythmogenic Right Ventricular Cardiomyopathy Hit paper breakdown → | 2017 | 466 |
| 12 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy Hit paper breakdown → | 2020 | 429 |
| 13 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy Hit paper breakdown → | 2020 | 392 |
| 14 | Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Hit paper breakdown → | 2015 | 368 |
| 15 | 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope Hit paper breakdown → | 2017 | 338 |
| 16 | Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis Hit paper breakdown → | 2015 | 324 |
| 17 | 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Hit paper breakdown → | 2017 | 316 |
| 18 | 2005 | 306 | |
| 19 | 2012 | 295 | |
| 20 | 1998 | 294 |
About Mark S. Link
Mark S. Link is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine, Surgery, Orthopedics and Sports Medicine and Biomedical Engineering, having authored 329 papers that have together received 24.2k indexed citations. Recurring topics across this work include Cardiovascular Effects of Exercise (108 papers), Cardiac electrophysiology and arrhythmias (75 papers), Cardiac pacing and defibrillation studies (73 papers), Cardiac Arrhythmias and Treatments (71 papers), Cardiac Arrest and Resuscitation (69 papers), Cardiomyopathy and Myosin Studies (61 papers), Cardiovascular Function and Risk Factors (23 papers) and Atrial Fibrillation Management and Outcomes (22 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (16.3k citations), Emergency Medicine (3.9k citations), Orthopedics and Sports Medicine (1.2k citations), Surgery (3.3k citations) and Complementary and alternative medicine (478 citations). Mark S. Link has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Barry J. Maron, N.A. Mark Estes, Martin S. Maron, James E. Udelson, Steve R. Ommen, Paul J. Wang, Clyde W. Yancy, Rick A. Nishimura, Robert O. Bonow and Jeffrey A. Towbin. Their work appears in journals such as Circulation, Journal of the American College of Cardiology, Heart Rhythm, The American Journal of Cardiology and Journal of Cardiovascular Electrophysiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.